US recommends ‘pause’ for J&J vaccine over clot reports
The Johnson & Johnson COVID-19 vaccine sits on a table at a pop-up vaccination site the Albanian Islamic Cultural Center, in the Staten Island borough of New York. (AP file photo/Mary Altaffer)
WASHINGTON – The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.
In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating clots in six women that occurred six to 13 days after vaccination. The clots were observed in the sinuses of the brain along with reduced platelet counts – making the usual treatment for blood clots, the blood thinner heparin, potentially “dangerous.”
CDC vaccine advisers will meet about Johnson & Johnson s vaccine tomorrow
From CNN s Ashley Ahn
A dose is drawn from a vial of the Johnson & Johnson COVID-19 vaccine at an event put on by the Thornton Fire Department on March 6 in Thornton, Colorado. Michael Ciaglo/Getty Images
The US Centers for Disease Control and Prevention will hold an emergency meeting of its Advisory Committee on Immunization Practices, or ACIP, from 1:30 to 4 p.m. ET Wednesday to review “rare and severe” blood clot cases among people who received the Johnson & Johnson Covid-19 vaccine.
The meeting will be virtual with no in-person attendance.
Federal agencies on Tuesday recommended a pause in the use of the vaccine following six cases of rare blood clots in individuals who received the single-dose shot.
US calls for pause in Johnson & Johnson vaccinations over blood clot concerns msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
US recommends pause for J&J vaccine to investigate rare reports of blood clots aspentimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aspentimes.com Daily Mail and Mail on Sunday newspapers.